A Dose Escalating Study of HC002 in Healthy Adult Volunteers

Clinical trial NCT06670274 · COMPLETED

Trial details

NCT number: NCT06670274
Sponsor: Holoclara Aus Pty Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Inflammatory Disease Autoimmune Diseases

Start date: 2024-11-21
Primary completion: 2025-03-31
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.